Diabetes: fake Ozempic injector pens circulating in Europe

European and French health authorities have warned against injector pens falsely labeled as Ozempic, a diabetes medication used for weight loss.



These fake pens were identified at distributors in Germany, Austria and the United Kingdom. Inactive serial numbers triggered the alert, but no falsified pens were issued to patients according to the European Medicines Agency.

The National Medicines Safety Agency (ANSM) called for vigilance and reiterated the need to verify the traceability of the serial number. No alert has been reported in France, but an investigation is underway.

  Pascal Lemontel

 WE RECOMMEND YOU

  > Cancer, diabetes: health concerns are mounting regarding several preservatives.

  > Aging well is becoming a strategy!

  > Online medications: the invisible danger and France at the forefront!

Nutri-score: better rated products, not necessarily more expensive!

A study by Public Health France, conducted with INRAE, challenges the idea that products with higher Nutri-Score ratings are systematically more expensive. The analysis, covering nearly 28,000 products ...

Medical appointments in France: waiting times are skyrocketing

According to the third barometer of the French Hospital Federation (FHF), getting an appointment with a general practitioner now takes three times longer than in 2019. The average wait time has reached ...

The safety of Covid-19 vaccines confirmed after 5 years of monitoring

The French National Agency for Medicines and Health Products Safety (ANSM) has announced the closure of its national pharmacovigilance investigation into mRNA vaccines against Covid-19, after five years ...

When and how to undergo a superficial peel

Want to give your skin a radiant boost and improve its elasticity with a superficial peel? Yes, provided you choose the right technique and take a few pre